Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pierre-Edouard, Debureaux
14  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic C..:

Delphine, Lebon ; Pierre-Edouard, Debureaux ; Bruno, Royer...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944873/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Prognosis of hyperviscosity syndrome in newly diagnosed mul..:

Pierre-Edouard Debureaux ; Stéphanie Harel ; Nathalie Parquet...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.1069360/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
3

DataSheet_1_Prognosis of hyperviscosity syndrome in newly d..:

Pierre-Edouard Debureaux ; Stéphanie Harel ; Nathalie Parquet...
doi:10.3389/fimmu.2022.1069360.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
4

Allogeneic transplantation in acute myelogenous leukemia: a..:

Socie, Gerard ; Galimard, Jacques-Emmanuel ; Raffoux, Emmanuel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483356/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic C..:

Lebon Delphine ; Debureaux Pierre-Edouard ; Royer Bruno...
https://www.mdpi.com/2076-3271/11/1/14.  , 2023
Link: https://doi.org/10.3390/..
 
?
6

Inflammation is predictive of outcome in Waldenström macrog..:

Debureaux, Pierre-Edouard ; Forgeard, Nathalie ; Elessa, Dikelele...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772506/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic C..:

Lebon Delphine ; Debureaux Pierre-Edouard ; Royer Bruno...
https://dx.doi.org/10.3390/medsci11010014.  , 2023
Link: https://doi.org/10.3390/..
 
?
8

Prognosis of hyperviscosity syndrome in newly diagnosed mul..:

Debureaux, Pierre-Edouard ; Harel, Stéphanie ; Parquet, Nathalie...
qt5xf2g061.  , 2022
Link: https://escholarship.org..
 
?
9

Prognosis of hyperviscosity syndrome in newly diagnosed mul..:

Debureaux, Pierre-Edouard ; Harel, Stéphanie ; Parquet, Nathalie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771682/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Molecular profiling and risk classification of patients wit..:

Debureaux, Pierre-Edouard ; Cassinat, Bruno ; Soret-Dulphy, Juliette...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422133/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

Fractionated gemtuzumab ozogamicin in association with high..:

Debureaux, Pierre-Edouard ; Labopin, Myriam ; Mamez, Anne-Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41409-019-0690-2.  , 2020
Link: https://hal.sorbonne-uni..
 
?
12

Fractionated gemtuzumab ozogamicin in association with high..:

Debureaux, Pierre-Edouard ; Labopin, Myriam ; Mamez, Anne-Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41409-019-0690-2.  , 2020
Link: https://hal.sorbonne-uni..
 
?
13

Elastography improves accuracy of early hepato-biliary comp..:

Debureaux, Pierre-Edouard ; Bourrier, Pierre ; Rautou, Pierre Emmanuel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409044/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Molecular profiling and risk classification of patients wit..:

Debureaux, Pierre-Edouard ; Cassinat, Bruno ; Soret-Dulphy, Juliette...
info:eu-repo/semantics/altIdentifier/pmid/32777065.  , 2020
Link: https://hdl.handle.net/2..
 
1-14